Delay hits start of Avigan clinical trials in Philippines

Wednesday, September 2nd, 2020. Filed under: Asian News News Philippine News

MANILA, Sept 2 (Mabuhay) — The clinical trials for anti-flu drug Avigan did not start as scheduled on Tuesday, September 1, Health Undersecretary Maria Rosario Vergeire said Wednesday.

Vergeire said this was because three hospitals participating in the clinical trials have yet to finish their ethics review on Avigan.

“Hindi ito naumpisahan kahapon kasi nagkaroon ng delay sa approval ng ethics review ng identified hospitals na kasama: iyong Dr. Jose N. Rodriguez Memorial Hospital, Sta. Ana Hospital at Quirino Memorial Medical Center,” Vergeire said.

The fourth hospital participating in the trial, Philippine General Hospital, has also yet to start the Avigan trial since the memorandum of agreement on the initiative is still undergoing legal review in UP Manila.

“We got inputs of legal officers [on the Avigan clinical trial], pipirmahan na lang po ni [Health] Secretary [Francisco Duque III]. Once the process is done we will immediately start,” Vergeire said.

Vergeire said that the clinical trials on Avigan drug will be administered on 100 patients.

The Avigan clinical trials were supposed to start in mid-August but it was moved to September 1.

The Department of Health will spend some P18 million for clinical trials on the efficacy of anti-flu drug Avigan on treating patients with COVID-19.

Vergeire also said that Phase 3 of clinical trials of Russian-made possible anti-COVID-19 vaccine Sputnik V in the Philippines is yet to be scheduled since Philippine authorities are yet to be informed if Phase 3 of such trial already started in Russia.

“Yung Sputnik V, hindi pa nag-uumpisa. Dapat mag umpisa iyong Phase 3 sa Russia ng August, but we have no information on that yet,” Vergeire said.

“Ang na-approve pa lang sa Russia ay yung for emergency use ng Sputnik V on their healthcare workers, and so our vaccine experts are still studying the Phase 1 and Phase 2 of Sputnik V trials,” she added.

The Philippines has 224,264 COVID-19 cases as of September 1. Of this number, 158,012 recovered while 3,597 died.

The number of active COVID-10 cases is at 62,655. (MNS)

ALSO READ: Philippines logs 3,483 new COVID-19 cases, total soars to 224,264Philippines logs 3,483 new COVID-19 cases, total soars to 224,264

Related posts

Duterte prefers Russia, China’s COVID-19 vaccines as other firms ask for advance payment1.5K Pinoys in UAE join Sinopharm’s vaccine clinical trialsDOH hopes to start Avigan trial in coming weeksRussia says Philippines may manufacture anti-COVID-19 vaccine Sputnik VLagundi clinical trials get FDA nod — DOST chief‘Vaccine hesitancy’ has dropped in Philippines, says DuquePRRD ‘most hopeful’ about potential China-made vaccineAvigan trial still awaiting finalization of legal documents –DOHCOVID-19 vaccine may be available in Philippines 2nd quarter of 2021 — DOHAvigan trials in PH still hasn’t started — DOHPH in talks with at least 16 COVID-19 vaccine developers – DOHSputnik V availability in Philippines seen by April 2021Beijing welcomes FDA approval of Chinese traditional medicineDOST to lead clinical trials for Covid-19 vaccine from RussiaPRRD accepts Russia’s CoVid-19 vaccine offerDuterte’s dilemma: After Russian vaccine, can I get COVID-19 shots from other countries?DOST expects VCO trial results will be released 2nd week of NovemberPalace assures Covid-19 vaccine’s affordabilityDOH earmarks initial P2.4 billion for purchase of vaccine vs. COVID-19DOH warns vs. illegal trade of recovered Covid patients’ plasma